ZA975770B - Anticonvulsant derivatives useful in treating psoriasis - Google Patents

Anticonvulsant derivatives useful in treating psoriasis

Info

Publication number
ZA975770B
ZA975770B ZA975770A ZA975770A ZA975770B ZA 975770 B ZA975770 B ZA 975770B ZA 975770 A ZA975770 A ZA 975770A ZA 975770 A ZA975770 A ZA 975770A ZA 975770 B ZA975770 B ZA 975770B
Authority
ZA
South Africa
Prior art keywords
derivatives useful
treating psoriasis
anticonvulsant derivatives
anticonvulsant
psoriasis
Prior art date
Application number
ZA975770A
Other languages
English (en)
Inventor
Richard P Shank
Claudia K Derian
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of ZA975770B publication Critical patent/ZA975770B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
ZA975770A 1996-06-28 1997-06-27 Anticonvulsant derivatives useful in treating psoriasis ZA975770B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2200596P 1996-06-28 1996-06-28

Publications (1)

Publication Number Publication Date
ZA975770B true ZA975770B (en) 1998-12-28

Family

ID=21807342

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975770A ZA975770B (en) 1996-06-28 1997-06-27 Anticonvulsant derivatives useful in treating psoriasis

Country Status (21)

Country Link
EP (1) EP0964681B1 (xx)
JP (1) JP4251410B2 (xx)
AP (1) AP1230A (xx)
AT (1) ATE204167T1 (xx)
AU (1) AU730868B2 (xx)
BR (1) BR9710992A (xx)
CA (1) CA2258891C (xx)
CZ (1) CZ294002B6 (xx)
DE (1) DE69706195T2 (xx)
DK (1) DK0964681T3 (xx)
ES (1) ES2160969T3 (xx)
HU (1) HUP0001637A3 (xx)
IL (1) IL127716A0 (xx)
NO (1) NO317567B1 (xx)
NZ (1) NZ333587A (xx)
PT (1) PT964681E (xx)
RU (1) RU2207854C2 (xx)
SK (1) SK284266B6 (xx)
UA (1) UA43449C2 (xx)
WO (1) WO1998000129A2 (xx)
ZA (1) ZA975770B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US8302024B2 (en) 2009-04-02 2012-10-30 Nintendo Of America Inc. Systems and/or methods for paging control including selective paging element display according to a binary subdivision and/or a serial progressive display approach
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4792569A (en) * 1987-08-27 1988-12-20 Mcneilab, Inc. Anticonvulsant phenethyl sulfamates

Also Published As

Publication number Publication date
BR9710992A (pt) 2000-10-24
AU3957797A (en) 1998-01-21
AP1230A (en) 2003-12-09
JP4251410B2 (ja) 2009-04-08
IL127716A0 (en) 1999-10-28
SK284266B6 (sk) 2004-12-01
AP9801430A0 (en) 1998-12-31
DE69706195D1 (de) 2001-09-20
CZ294002B6 (cs) 2004-09-15
AU730868B2 (en) 2001-03-15
NO317567B1 (no) 2004-11-15
NO986053L (no) 1999-02-23
PT964681E (pt) 2001-11-30
EP0964681B1 (en) 2001-08-16
CZ427698A3 (cs) 1999-08-11
CA2258891A1 (en) 1998-01-08
UA43449C2 (uk) 2001-12-17
ATE204167T1 (de) 2001-09-15
CA2258891C (en) 2005-09-20
WO1998000129A2 (en) 1998-01-08
DK0964681T3 (da) 2001-10-08
DE69706195T2 (de) 2002-05-02
NO986053D0 (no) 1998-12-22
HUP0001637A2 (hu) 2002-01-28
NZ333587A (en) 2000-07-28
HUP0001637A3 (en) 2002-04-29
SK180398A3 (en) 2000-01-18
ES2160969T3 (es) 2001-11-16
EP0964681A2 (en) 1999-12-22
WO1998000129A3 (en) 1998-02-12
JP2000514796A (ja) 2000-11-07
RU2207854C2 (ru) 2003-07-10

Similar Documents

Publication Publication Date Title
ZA975772B (en) Anticonvulsant derivatives useful in treating obesity
ZA975773B (en) Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
HRP970063B1 (en) Triazole derivatives useful in therapy
GB9609641D0 (en) Compounds useful in therapy
EG24222A (en) Spiro-azabicyclic compounds useful in therapy
GB9526546D0 (en) Compounds useful in therapy
ZA975769B (en) Anticonvulsant derivatives useful in treating acute ischemia-induced neurodegeneration
IL129276A (en) Anticonvulsant derivatives useful in treating neuropathic pain
DE69732623D1 (en) Analogsignalmultiplexer in strombetriebsart
PL328964A1 (en) Acne treating method
ZA975770B (en) Anticonvulsant derivatives useful in treating psoriasis
GB9604400D0 (en) Compounds useful in therapy
SI0964681T1 (en) Anticonvulsant derivatives useful in treating psoriasis
GB2319543B (en) Improvements in cladding
GB9611821D0 (en) Reduction process
GB9511585D0 (en) Compounds useful in therapy
GB9523135D0 (en) Compounds useful in therapy
GB9511583D0 (en) Compounds useful in therapy
GB9519912D0 (en) Improvements in bioprocessors
GB9521694D0 (en) Improvements in electrophoresis
SI0915697T1 (en) Anticonvulsant sulfamate derivatives useful in treating obesity
HU9400235V0 (en) Drink-paccked in boxes-pouring
GB9602513D0 (en) Compounds and process
GB9411244D0 (en) Compounds useful in therapy
GB9411293D0 (en) Compounds useful in therapy